SCHEMBL5857393

SCHEMBL5857393

CC(=CC(=O)C(F)(F)F)c1ccc(C)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.58
▸ NR4A1 P22736 1/20 0.50
▸ NR4A2 P43354 1/20 0.50
▸ NR4A3 Q92570 1/20 0.50
▸ CA2 P00918 1/20 0.46
▸ ALDH1A1 P00352 7/20 0.44
▸ HTT P42858 3/20 0.44
▸ NPSR1 Q6W5P4 3/20 0.44
▸ LMNA P02545 3/20 0.44
▸ SMN1; SMN2 Q16637 3/20 0.44
▸ TDP1 Q9NUW8 3/20 0.44
▸ PKM P14618 2/20 0.44
▸ ATM Q13315 2/20 0.44
▸ HPGD P15428 2/20 0.44
▸ NLRP1 Q9C000 1/20 0.44
▸ MEN1 O00255 1/20 0.44
▸ NTSR1 P30989 1/20 0.44
▸ KMT2A Q03164 1/20 0.44
▸ CES2 O00748 2/20 0.43
▸ CES1 P23141 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5857387 1.00 MAPT (0.58) MAPTNR4A1NR4A2NR4A3CA2
SCHEMBL13246761 0.83 ALDH1A1 (0.45) MAPTNR4A1NR4A2NR4A3CA2
SCHEMBL5858029 0.83 NR4A1 (0.51) MAPTNR4A1NR4A2NR4A3CA2
SCHEMBL5858034 0.83 NR4A1 (0.51) MAPTNR4A1NR4A2NR4A3CA2
SCHEMBL25142179 0.81 MAPT (0.54) MAPTCA2ALDH1A1HTTNPSR1
SCHEMBL14731820 0.78 ALDH1A1 (0.52) MAPTNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL9609511 0.78 ALDH1A1 (0.52) MAPTNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL12921562 0.78 ALDH1A1 (0.52) MAPTNR4A1NR4A2NR4A3ALDH1A1
SCHEMBL25150400 0.78 NR4A1 (0.42) MAPTNR4A1NR4A2NR4A3CA2
SCHEMBL2697768 0.77 MAPT (0.50) MAPTCA2ALDH1A1HTTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE38963-E1 Pyrazoline derivatives, their preparation and application as medicaments LABORATORIOS DEL DR. ESTEVE (ES) 2006-01-31 — — US disclosed
EP-1083171-B1 PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS MEDICAMENTS ESTEVE LABOR DR (ES) 2004-04-28 — — EP disclosed
US-6353117-B1 ANTIINFLAMMATORY ACTIVITY AND DISEASES IN WHICH CYCLOOXYGENASE-2 PLAYS A PART, WITHOUT HAVING THE GASTRIC AND RENAL TOXICITY OF THE CLASSIC NONSTEROIDAL ANTIINFLAMMATORY AGENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2002-03-05 — — US disclosed
EP-1083171-A1 PYRAZOLINE DERIVATIVES, THEIR PREPARATION AND APPLICATION AS MEDICAMENTS LABORATORIOS DEL DR. ESTEVE, S.A. (ES) 2001-03-14 — — EP disclosed
Send feedback